Business Description
Ever Supreme Bio Technology Co Ltd
ISIN : TW0006712003
Description
Ever Supreme Bio Technology Co Ltd is a Taiwan based company. The company is engaged in research, developing, and manufacturing new drugs related to human mesenchymal stem cells and immune cells.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 147.29 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.02 | |||||
| Interest Coverage | 2273.68 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 34.88 | |||||
| Beneish M-Score | -2.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 113.6 | |||||
| 3-Year Book Growth Rate | 29.7 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.4 | |||||
| 9-Day RSI | 43.99 | |||||
| 14-Day RSI | 43.44 | |||||
| 6-1 Month Momentum % | 3.81 | |||||
| 12-1 Month Momentum % | 4.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.57 | |||||
| Quick Ratio | 6.19 | |||||
| Cash Ratio | 5.79 | |||||
| Days Inventory | 120.21 | |||||
| Days Sales Outstanding | 35.14 | |||||
| Days Payable | 30.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1 | |||||
| Dividend Payout Ratio | 0.33 | |||||
| Forward Dividend Yield % | 3.02 | |||||
| 5-Year Yield-on-Cost % | 0.99 | |||||
| 3-Year Average Share Buyback Ratio | -2.7 | |||||
| Shareholder Yield % | 1.07 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.42 | |||||
| Operating Margin % | 50.85 | |||||
| Net Margin % | 55.41 | |||||
| FCF Margin % | 51.18 | |||||
| ROE % | 24.27 | |||||
| ROA % | 21.7 | |||||
| ROIC % | 46.49 | |||||
| ROC (Joel Greenblatt) % | 693.01 | |||||
| ROCE % | 29.21 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 33.22 | |||||
| PE Ratio without NRI | 33.21 | |||||
| Price-to-Owner-Earnings | 36.28 | |||||
| PS Ratio | 18.39 | |||||
| PB Ratio | 7.82 | |||||
| Price-to-Tangible-Book | 7.79 | |||||
| Price-to-Free-Cash-Flow | 35.83 | |||||
| Price-to-Operating-Cash-Flow | 35.34 | |||||
| EV-to-EBIT | 24.34 | |||||
| EV-to-EBITDA | 23.03 | |||||
| EV-to-Revenue | 16.33 | |||||
| EV-to-FCF | 32.27 | |||||
| Price-to-Graham-Number | 3.37 | |||||
| Price-to-Net-Current-Asset-Value | 10.74 | |||||
| Price-to-Net-Cash | 12.53 | |||||
| Earnings Yield (Greenblatt) % | 4.11 | |||||
| FCF Yield % | 2.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ever Supreme Bio Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 804.843 | ||
| EPS (TTM) (NT$) | 5.99 | ||
| Beta | 0.46 | ||
| Volatility % | 15.04 | ||
| 14-Day RSI | 43.44 | ||
| 14-Day ATR (NT$) | 4.804477 | ||
| 20-Day SMA (NT$) | 202.95 | ||
| 12-1 Month Momentum % | 4.11 | ||
| 52-Week Range (NT$) | 170 - 229 | ||
| Shares Outstanding (Mil) | 73.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ever Supreme Bio Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ever Supreme Bio Technology Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ever Supreme Bio Technology Co Ltd Frequently Asked Questions
What is Ever Supreme Bio Technology Co Ltd(ROCO:6712)'s stock price today?
The current price of ROCO:6712 is NT$197.00. The 52 week high of ROCO:6712 is NT$229.00 and 52 week low is NT$170.00.
When is next earnings date of Ever Supreme Bio Technology Co Ltd(ROCO:6712)?
The next earnings date of Ever Supreme Bio Technology Co Ltd(ROCO:6712) is .
Does Ever Supreme Bio Technology Co Ltd(ROCO:6712) pay dividends? If so, how much?
The Dividend Yield %  of Ever Supreme Bio Technology Co Ltd(ROCO:6712) is 1% (As of Today), Highest Dividend Payout Ratio of Ever Supreme Bio Technology Co Ltd(ROCO:6712) was 1.71. The lowest was 0.28. And the median was 0.99. The  Forward Dividend Yield % of Ever Supreme Bio Technology Co Ltd(ROCO:6712) is 3.02%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers